完全置入式静脉港并发症及管理
Complications and Management Strategies of Totally Implantable Venous Access Devices
DOI: 10.12677/MD.2023.132036, PDF,    科研立项经费支持
作者: 郭宸君, 郭学君, 杨 越*：昆明市第一人民医院乳腺科，云南 昆明
关键词: 静脉港；并发症；化疗；Implantable Venous Access Devices (IVADs)； Complication； Chemotherapy
摘要: 完全置入式静脉港(Totally Implantable Venous Access Devices)是由一个在皮下组织中放置的储槽及与之连接的导管组成，而导管的末端位于中心静脉。静脉港是目前较为安全的一种方式，但仍存在一定的并发症。在这其中静脉港的设计及使用材料的不同对并发症的发生率有一定的影响。本文将从设计、材料、放置静脉港、留置静脉港方面分析相关并发症及预防方法。
Abstract: The Totally Implantable Venous Access Devices is composed of a reservoir placed in the subcuta-neous tissue and a catheter connected to it, and the end of the catheter is located in the central vein. Venous port is currently a relatively safe method, but there are still certain complications. Among them, the design of the venous port and the different materials used have a certain impact on the incidence of complications. This article will analyze the related complications and preventive methods from the aspects of design, materials, placement of venous port, and indwelling venous port.
文章引用：郭宸君, 郭学君, 杨越. 完全置入式静脉港并发症及管理[J]. 医学诊断, 2023, 13(2): 218-230. https://doi.org/10.12677/MD.2023.132036

参考文献

[1] Niederhuber, J.E., Ensminger, W., Gyves, J.W., et al. (198) Totally Implanted venous and Arterial Access System to Re-place External Catheters in Cancer Treatment. Surgery, 92, 706-712.
[2] Gyves, J., Ensminger, W., Niederhuber, J., et al. (1982) Totally Implanted System for Intravenous Chemotherapy in Patients with Cancer. The American Journal of Medicine, 73, 841-845. [Google Scholar] [CrossRef] [PubMed]
[3] Gallieni, M., Pittiruti, M. and Biffi, R. (2008) Vascular Access in Oncology Patients. CA, 58, 323-346. [Google Scholar] [CrossRef] 
[4] Wu, O., Boyd, K., Paul, J., McCartney, E., Ritchie, M., Mellon, D., Kelly, L., Dixon-Hughes, J. and Moss, J. (2016) Hickman Catheter and Implantable Port Devices for the Delivery of Chemotherapy: A Phase II Randomised Controlled Trial and Economic Evaluation. British Journal of Cancer, 114, 979-985. [Google Scholar] [CrossRef] [PubMed]
[5] Di Carlo, I., Pulvirenti, E., Mannino, M. and Toro, A. (2010) Increased Use of Percutaneous Technique for Totally Implantable venous Access Devices. Is It Real Progress? A 27-Year Comprehensive Review on Early Complications. Annals of Surgical Oncology, 17, 1649-1656. [Google Scholar] [CrossRef] [PubMed]
[6] Carausu, L., Clapisson, G., Philip, I., Sebban, H and Marec-Bérard, P (2007) Use of Totally Implantable Catheters for Peripheral Blood Stem Cell Apheresis. Bone Marrow Transplantation, 40, 417-422. [Google Scholar] [CrossRef] [PubMed]
[7] Munro, F.D., Gillett, P.M., Wratten, J.C., et al. (1999) Totally Im-plantable Central venous Access Devices for Paediatric Oncology Patients. Medical and Pediatric Oncology, 33, 377-381. [Google Scholar] [CrossRef] 
[8] LaRoy, J.R., White, S.B., Jayakrishnan, T., et al. (2015) Cost and Morbidity Analysis of Chest Port Insertion: Interventional radiology Suite versus Operating Room. Journal of the American College of Radiology, 12, 563-571. [Google Scholar] [CrossRef] [PubMed]
[9] Etezadi, V. and Trerotola, S.O. (2017) Comparison of Inversion (“Flipping”) Rates among Different Port Designs: A Single-Center Experience. CardioVascular and Interventional Radi-ology, 40, 553-559. [Google Scholar] [CrossRef] [PubMed]
[10] Mansfield, P.F., Hohn, D.C., Fornage, B.D., Gregurich, M.A. and Ota, D.M. (1994) Complications and Failures of Subclavian-Vein Catheterization. The New England Journal of Medicine, 331, 1735-1738. [Google Scholar] [CrossRef] 
[11] Voog, E., et al. (2018) Totally Implantable venous Access Ports: A Prospective Long-Term Study of Early and Late Complications in Adult Patients with Cancer. Supportive Care in Cancer, 26, 81-89. [Google Scholar] [CrossRef] [PubMed]
[12] Narducci, F., Jean-Laurent, M., Boulanger, L., El Bédoui, S., Mallet, Y., Houpeau, J.L., Hamdani, A., Penel, N. and Fournier, C. (2011) Totally Implantable venous Access Port Sys-tems and Risk Factors for Complications: A One-Year Prospective Study in a Cancer Centre. European Journal of Sur-gical Oncology, 37, 913-918. [Google Scholar] [CrossRef] [PubMed]
[13] Granziera, E., Scarp,a M., Ciccarese, A., et al. (2014) Totally Im-plantable venous Access Devices: Retrospective Analysis of Different Insertion Techniques and Predictors of Complica-tions in 796 Devices Implanted in a Single Institution. BMC Surgery, 14, Article No. 27. [Google Scholar] [CrossRef] [PubMed]
[14] Chand, R., Sertic, M., Nemec, R., et al. (2015) Use of Vascular Ports for Long-Term Apheresis in Children. The Journal of Vascular and Interventional Radiology, 26, 1669-1672. [Google Scholar] [CrossRef] [PubMed]
[15] Gonzalez, A., Sodano, D., Flanagan, J., Ouillette, C. and Weinstein, R. (2004) Long-Term Therapeutic Plasma Exchange in the Outpatient Setting Using an Implantable Central venous Ac-cess Device. Journal of Clinical Apheresis, 19, 180-184. [Google Scholar] [CrossRef] [PubMed]
[16] Pertiné, B., Razvi, S.A. and Weinstein, R. (2002) Prospective Investigation of a Subcutaneous, Implantable Central venous Access Device for Therapeutic Plasma Exchange in Adults with Neurological Disorders. The Journal of Clinical Apheresis, 17, 1-6.
[17] ZotteleBomfim, G.A., Wolosker, N., Yazbek, G., et al. (2014) Comparative Study of Valved and Nonvalved Fully Implantable Catheters Inserted via Ultrasound-Guided Puncture for Chemotherapy. Annals of Vascular Surgery, 28, 351-357. [Google Scholar] [CrossRef] [PubMed]
[18] Carlo, J.T., Lamont, J.P., McCarty, T.M., Sheryl Liv-ingston, R.N. and Kuhn, J.A. (2004) A Prospective Randomized Trial Demonstrating Valved Implantable Ports Have Fewer Complications and Lower Overall Cost than Nonvalved Implantable Ports. The American Journal of Surgery, 188, 722-727. [Google Scholar] [CrossRef] [PubMed]
[19] Biffi, R., De Braud, F., Orsi, F., et al. (2001) A Ran-domized, Prospective Trial of Central venous Ports Connected to Standard Openended or Groshong Catheters in Adult Oncology Patients. Cancer, 92, 1204-1212. [Google Scholar] [CrossRef] 
[20] Lamont, J.P., McCarty, T.M., Stephens, J.S., Smith, B.A., Carlo, J., Livingston, S. and Kuhn, J.A. (2003) A Randomized Trial of Valved vs Nonvalved Implantable Ports for Vascular Access. Baylor University Medical Center Proceedings, 16, 384-387. [Google Scholar] [CrossRef] [PubMed]
[21] Raj, A., Bertolone, S., Bond, S., Burnett, D. and Denker, A. (2005) Cathlink® 20: A Subcutaneous Implanted Central venous Access Device Used in Children with Sick-le Cell Disease on Long-Term Erythrocytapheresis—Areport of Low Complication Rates. Pediatric Blood & Cancer, 44, 669-672. [Google Scholar] [CrossRef] [PubMed]
[22] Dezfulian, C., Lavelle, J., Nallamothu, B.K., et al. (2003) Rates of Infection for Single-Lumen versus Multilumen Central venous Catheters: A Meta-Analysis. Critical Care Medicine, 31, 2385-2390. [Google Scholar] [CrossRef] 
[23] Teichgraber, U.K., Nagel, S.N., Kausche, S., et al. (2010) Double-lumen Central venous Port Catheters: Simultaneous Application for Chemotherapy and Parenteral Nutrition in Cancer Patients. The Journal of Vascular Access, 11, 335-341. [Google Scholar] [CrossRef] 
[24] Blanco-Guzman, M.O. (2018) Implanted Vascular Access Device Options: A Focused Review on Safety and Outcomes. Transfusion, 58, 558-568. [Google Scholar] [CrossRef] [PubMed]
[25] Wildgruber, M., Lueg, C., Borgmeyer, S., et al. (2016) Polyurethane versus Silicone Catheters for Central Venous Port Devices Implanted at the Forearm. European Journal of Cancer, 59, 113-124. [Google Scholar] [CrossRef] [PubMed]
[26] Wildgruber, M., Lueg, C., Borgmeyer, S., et al. (2016) Polyure-thane versus Silicone Catheters for Central Venous Port Devices Implanted at the Forearm. European Journal of Cancer, 59, 113-124. [Google Scholar] [CrossRef] [PubMed]
[27] O’Grady, N.P., Alexander, M., Burns, L.A., et al. (2011) Guide-lines for the Prevention of Intravascular Catheter-Related Infections. Clinical Infectious Diseases, 52, e162-e193. [Google Scholar] [CrossRef] [PubMed]
[28] Nelson, E.T., Gross, M.E., Mone, M.C., et al. (2013) A Survey of Ameri-can College of Surgery Fellows Evaluating Their Use of Antibiotic Prophylaxis in the Placement of Subcutaneously Im-planted Central venous Access Ports. The American Journal of Surgery, 206, 1034-1040. [Google Scholar] [CrossRef] [PubMed]
[29] Johnson, E., Babb, J. and Sridhar, D. (2016) Routine Antibiotic Prophylaxis for Totally Implantable venous Access Device Placement: Meta-Analysis of 2,154 Patients. The Journal of Vascular and Interventional Radiology, 27, 339-343. [Google Scholar] [CrossRef] [PubMed]
[30] Morris, S.L., Jaques, P.F. and Mauro, M.A. (1992) Radiology-Assisted Placement of Implantable Subcutaneous Infusion Ports for Longterm venous Access. Radiology, 184, 149-151. [Google Scholar] [CrossRef] [PubMed]
[31] Biffi, R., Toro, A., Pozzi, S.andDi Carlo, I. (2014) Totally Implantable Vascular Access Devices 30 Years after the First Procedure. What Has Changed and What Is Still Unsolved? Supportive Care in Cancer, 22, 1705-1714. [Google Scholar] [CrossRef] [PubMed]
[32] Hind, D., Calvert, N., McWilliams, R., et al. (2003) Ultrasonic Locating Devices for Central venous Cannulation: Meta-Analysis. BMJ, 327, 361-367. [Google Scholar] [CrossRef] [PubMed]
[33] Knebel, P., Fischer, L., Huesing, J., Hennes, R., Büchler, M.W. and Seiler, C.M. (2009) Randomized Clinical Trial of a Modified Seldinger Technique for Open Central venous Cannulation for Implantable Access Devices. British Journal of Surgery, 96, 159-165. [Google Scholar] [CrossRef] [PubMed]
[34] Biffi, R., Orsi, F., Pozzi, S., et al. (2009) Best Choice of Central venous In-sertion Site for the Prevention of Catheter- Related Complicationsin Adult Patients Who Need Cancer Therapy: A Ran-domized Trial. Annals of Oncology, 20, 935-940. [Google Scholar] [CrossRef] [PubMed]
[35] Hsu, C.C., Kwan, G.N., Evans-Barns, H., et al. (2016) Venous Cutdown versus the Seldinger Technique for Placement of Totally Im-plantable venous Access Ports. Cochrane Database of Systematic Reviews, 8, CD008942. [Google Scholar] [CrossRef] 
[36] McGee, D.C. and Gould, M.K. (2003) Preventing Com-plications of Central Venous Catheterization. The New England Journal of Medicine, 348, 1123-1133. [Google Scholar] [CrossRef] 
[37] Mudan, S., Giakoustidis, A., Morrison, D., Iosifidou, S., Raobaikady, R., Neofytou, K. and Stebbing, J. (2015) 1000 Port-A-Cath® Placements by Subclavian Vein Approach: Single Surgeon Experience. World Journal of Surgery, 39, 328-334. [Google Scholar] [CrossRef] [PubMed]
[38] Orci, L.A., Meier, R.P., Morel, P., et al. (2014) System-atic Review and Metaanalysis of Percutaneous Subclavian Vein Puncture versus Surgical venous Cutdown for the Inser-tion of a Totally Implantable venous Access Device. British Journal of Surgery, 101, 8-16. [Google Scholar] [CrossRef] [PubMed]
[39] Brass, P., Hellmich, M., Kolodziej, L., et al. (2015) Ultrasound Guid-ance versus Anatomical Landmarks for Internal Jugular Vein Catheterization. Cochrane Database of Systematic Reviews, 1, CD006962. [Google Scholar] [CrossRef] 
[40] Plumhans, C., Mahnken, A.H., Ocklenburg, C., et al. (2011) Jugular versus Subclavian Totally Implantable Access Ports: Catheter Position, Complications and Intrainterven-tional Pain Perception. European Journal of Radiology, 79, 338-342. [Google Scholar] [CrossRef] [PubMed]
[41] Matsushima, H., Adachi, T., Iwata, T., et al. (2016) Analysis of the Outcomes in Central venous Access Port Implantation Performed by Residents via the Internal Jugular Vein and Sub-clavian Vein. Journal of Surgical Education, 74, 443-449. [Google Scholar] [CrossRef] [PubMed]
[42] Kakkos, A., Bresson, L., et al. (2017) Complication-Related Removal of Totally Implantable venous Access Port Systems: Does the Interval between Placement and First Use and the Neutropenia-Inducing Potential of Chemotherapy Regimens Influ-ence Their Incidence? A Four-Year Prospective Study of 4045 Patients. EJSO, 43, 689-695. [Google Scholar] [CrossRef] [PubMed]
[43] Nagasawa, Y., Shimizu, T., Sonoda, H., et al. (2014) A Compari-son of Outcomes and Complications of Totally Implantable Access Port through the Internal Jugular Vein versus the Subclavian Vein. International Surgery, 99, 182-188. [Google Scholar] [CrossRef] 
[44] Schiffer, C.A., Mangu, P.B., Wade, J.C., et al. (2013) Central venous Catheter Care for the Patient with Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of Clinical Oncology, 31, 1357-1370. [Google Scholar] [CrossRef] 
[45] Kusminsky, R.E. (2007) Complications of Central venous Cathe-terization. Journal of the American College of Surgeons, 204, 681-696. [Google Scholar] [CrossRef] [PubMed]
[46] Baumann, M.H. and Noppen, M. (2004) Pneumo-thorax. Respirology, 9, 157-164. [Google Scholar] [CrossRef] [PubMed]
[47] Barbetakis, N., Asteriou, C., Kleontas, A., et al. (2011) Totally Implantable Central venous Access Ports. Analysis of 700 Cases. Journal of Surgical Oncology, 104, 654-656. [Google Scholar] [CrossRef] [PubMed]
[48] Kim, J.T., Oh, T.Y., Chang, W.H. and Jeong, Y.K. (2012) Clinical Review and Analysis of Complications of Totally Implantable venous Access Devices for Chemotherapy. Medical On-cology, 29, 1361-1364. [Google Scholar] [CrossRef] [PubMed]
[49] Tsotsolis, N., Tsirgogianni, K., Kioumis, I., et al. (2015) Pneu-mothorax as a Complication of Central venous Catheter Insertion. Annals of Translational Medicine,3, 40.
[50] Pikwer, A., Baath, L., Perstoft, I., et al. (2009) Routine Chest X-Ray Is Not Required after a Low-Risk Central venous Cannula-tion. ActaAnaesthesiologicaScandinavica, 53, 1145-1152. [Google Scholar] [CrossRef] [PubMed]
[51] Chang, H.M., Hsieh, C.B., Hsieh, H.F., et al. (2006) An Alternative Technique for Totally Implantable Central venous Access Devices. A Retrospective Study of 1311 Cases. European Journal of Surgical Oncology, 32, 90-93. [Google Scholar] [CrossRef] [PubMed]
[52] Frykholm, P., Pikwer, A., Hammarskjold, F., et al. (2014) Clinical Guidelines on Central venous Catheterisation. Swedish Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiologica Scandinavica, 58, 508-524. [Google Scholar] [CrossRef] [PubMed]
[53] Thomopoulos, T., Meyer, J., Staszewicz, W., et al. (2014) Routine Chest X-Ray Is Not Mandatory after Fluoroscopy-Guided Totally Implantable venous Access Device Insertion. Annals of Vascular Surgery, 28, 345-350. [Google Scholar] [CrossRef] [PubMed]
[54] Brown, J.R., Slomski, C. and Saxe, A.W. (2009) Is Routine Post-operative Chest X-Ray Necessary after Fluoroscopic-Guided Subclavian Central venous Port Placement? Journal of the American College of Surgeons, 208, 517-519. [Google Scholar] [CrossRef] [PubMed]
[55] Plaus, W.J. (1990) Delayed Pneumothorax after Subclavian Vein Catheterization. Journal of Parenteral and Enteral Nutrition, 14, 414-415. [Google Scholar] [CrossRef] [PubMed]
[56] Laronga, C., Meric, F., Truong, M.T., et al. (2000) A Treatment Algorithm for Pneumothoraces Complicating Central venous Catheter Insertion. The American Journal of Surgery, 180, 523-526. [Google Scholar] [CrossRef] 
[57] Tavare, A.N., Creer, D.D., Khan, S., et al. (2016) Ambula-tory Percutaneous Lung Biopsy with Early Discharge and Heimlich Valve Management of Iatrogenic Pneumothorax: More for Less. Thorax, 71, 190-192. [Google Scholar] [CrossRef] [PubMed]
[58] Baumann, M.H., Strange, C., Heffner, J.E., et al. (2001) Management of Spontaneous Pneumothorax: An American College of Chest Physicians Delphi Consensus Statement. Chest, 119, 590-602. [Google Scholar] [CrossRef] [PubMed]
[59] Haynes, D. and Baumann, M.H. (2010) Management of Pneumotho-rax. Seminars in Respiratory and Critical Care Medicine, 31, 769-780. [Google Scholar] [CrossRef] [PubMed]
[60] Innami, Y., Oyaizu, T., Ouchi, T., Umemura, N. and Koita-bashi, T. (2009) Life-Threatening Hemothorax Resulting from Right Brachiocephalic Vein Perforation during Right In-ternal Jugular Vein Catheterization. Journal of Anesthesia, 23, 135-138. [Google Scholar] [CrossRef] [PubMed]
[61] Innami, Y., Oyaizu, T., Ouchi, T., Umemura, N. and Koitabashi, T. (2009) Life-Threatening Hemothorax Resulting from Right Brachiocephalic Vein Perforation during Right Internal Jugular Vein Catheterization. Journal of Anesthesia, 23, 135-138. [Google Scholar] [CrossRef] [PubMed]
[62] Kulvatunyou, N., Heard, S.O. and Bankey, P.E. (2002) A Subclavian Artery Injury, Secondary to Internal Jugular Vein Cannulation, Is a Predictable Right-Sided Phenomenon. Anesthesia & Analgesia, 95, 564-566. [Google Scholar] [CrossRef] 
[63] Chung, J.H., Cox, C.W., Mohammed, T.L., et al. (2014) ACR Appropriateness Criteria Blunt Chest Trauma. Journal of the American College of Radiology, 11, 345-351. [Google Scholar] [CrossRef] [PubMed]
[64] Tokue, H., Tsushima, Y., Morita, H., et al. (2009) Suc-cessful Interventional Management for Subclavian Artery Injury Secondary to Internal Jugular Catheterization: A Report of Two Cases. CardioVascular and Interventional Radiology, 32, 1268-1271. [Google Scholar] [CrossRef] [PubMed]
[65] Ruesch, S., Walder, B. and Tramer, M.R. (2002) Com-plications of Central venous Catheters: Internal Jugular versus Subclavian Access—A Systematic Review. Critical Care Medicine, 30, 454-460. [Google Scholar] [CrossRef] [PubMed]
[66] Mercer-Jones, M.A., Wenstone, R. and Hershman, M.J. (1995) Fatal Subclavian Artery Haemorrhage. A Complication of Subclavian Vein Catheterisation. Anaesthesia, 50, 639-640. [Google Scholar] [CrossRef] [PubMed]
[67] O’Leary, A.M. (1990) Acute Upper Airway Obstruction Due to Arterial Puncture during Percutaneous Central venous Cannulation of the Subclavian Vein. Anesthe-siology, 73, 780-782. [Google Scholar] [CrossRef] 
[68] Tarng, D.C., Huang, T.P. and Lin, K.P. (1998) Brachial Plexus Compression Due to Subclavian Pseudoaneurysm from Cannulation of Jugular Vein Hemo-dialysis Catheter. American Journal of Kidney Diseases, 31, 694-697. [Google Scholar] [CrossRef] [PubMed]
[69] Flanagan, J.P., Gradisar, I.A., Gross, R.J., et al. (1969) Air Embolus—A Lethal Complication of Subclavian Venipuncture. The New England Journal of Medicine, 281, 488-489. [Google Scholar] [CrossRef] 
[70] Khan, H. and Zaidi, A. (2013) Paradoxical Air Embolism Following Central venous Catheter Removal. BMJ Case Reports, 2013. [Google Scholar] [CrossRef] [PubMed]
[71] daEum, H., Lee, S.H., Kim, H.W., et al. (2015) Cerebral Air Embolism Following the Removal of a Central venous Catheter in the Absence of Intracardiac Right-to-Left Shunting: A Case Report. Medicine, 94, e630. [Google Scholar] [CrossRef] 
[72] Heckmann, J.G., Lang, C.J., Kindler, K., et al. (2000) Neu-rologic Manifestations of Cerebral Air Embolism as a Complication of Central venous Catheterization. Critical Care Medicine, 28, 1621-1625. [Google Scholar] [CrossRef] [PubMed]
[73] Mirski, M.A., Lele, A.V., Fitzsimmons, L., et al. (2007) Diagnosis and Treatment of Vascular Air Embolism. Anesthesiology, 106, 164-177. [Google Scholar] [CrossRef] [PubMed]
[74] Kurul, S., Saip, P. and Aydin, T. (2002) Totally Implantable Venous-Access Ports: Local Problems and Extravasation Injury. The Lancet Oncology, 3, 684-692. [Google Scholar] [CrossRef] 
[75] Zawacki, W.J., Walker, T.G., DeVasher, E., et al. (2009) Wound Dehiscence or Failure to Heal Following venous Access Port Placement in Patients Receiving Bevaci-zumab Therapy. The Journal of Vascular and Interventional Radiology, 20, 624-627. [Google Scholar] [CrossRef] [PubMed]
[76] Erinjeri, J.P., Fong, A.J., Kemeny, N.E., et al. (2011) Timing of Administration of Bevacizumab Chemotherapy Affects Wound Healing after Chest Wall Port Placement. Can-cer, 117, 1296-1301. [Google Scholar] [CrossRef] [PubMed]
[77] Ghayyda, S.N., Roland, D. and Cade, A. (2008) Seat Belt Associated Central Line Fracture-A Previously Unreported Complication in Cystic Fibrosis. Journal of Cystic Fi-brosis, 7, 448-449. [Google Scholar] [CrossRef] [PubMed]
[78] Schulmeister, L. (2008) Managing Vesicant Ex-travasations. Oncologist, 13, 284-288. [Google Scholar] [CrossRef] [PubMed]
[79] US Food and Drug Administration (FDA), US Department of Health and Human Services. Safety Investigation of Non-Coring(Huber)Needles.FDA;2010.July11, 2016.
http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm198766.htm
[80] Nesti, S.P. and Kovac, R. (2000) 5-Fluorouracil Extravasation Following Port Failure. Journal of Infusion Nursing, 23, 176-180.
[81] Rudolph, R. and Larson, D.L. (1987) Etiology and Treatment of Chemotherapeutic Agent Extravasation Injuries: A Review. Journal of Clinical Oncology, 5, 1116-1126. [Google Scholar] [CrossRef] 
[82] Ener, R.A., Meglathery, S.B. and Styler, M. (2004) Extravasation of Systemic Hemato-Oncological Therapies. Annals of Oncology, 15, 858-862. [Google Scholar] [CrossRef] [PubMed]
[83] Wengstrom, Y. and Margulies, A. (2008) European Oncol-ogy Nursing Society Extravasation Guidelines. European Journal of Oncology Nursing, 12, 357-361. [Google Scholar] [CrossRef] [PubMed]
[84] Perez Fidalgo, J.A., Garcia Fabregat, L., Cervantes, A., et al. (2012) Management of Chemotherapy Extravasation: ESMO-EONS Clinical Practice Guidelines. European Journal of Oncology Nursing, 16, 528-534. [Google Scholar] [CrossRef] [PubMed]
[85] Goossens, G.A., Stas, M., Jerome, M., et al. (2011) Systematic Review: Malfunction of Totally Implantable venous Access Devices in Cancer Patients. Supportive Care in Cancer, 19, 883-898. [Google Scholar] [CrossRef] [PubMed]
[86] Goossens, G.A., De Waele, Y., Jerome, M., et al. (2016) Diag-nostic Accuracy of the Catheter Injection and Aspiration (CINAS) Classification for Assessing the Function of Totally Implantable venous Access Devices. Supportive Care in Cancer, 24, 755-761. [Google Scholar] [CrossRef] [PubMed]
[87] Kearon, C., Ak, E.A., Comerota, A.J., et al. (2012) An-tithrombotic Therapy for VTE Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest, 141, e419S-e96S. [Google Scholar] [CrossRef] 
[88] Kearon, C., Akl, E.A., Ornelas, J., et al. (2016) An-tithrombotic Therapy for VTE Disease. CHEST Guideline and Expert Panel Report. Chest, 149, 315-352. [Google Scholar] [CrossRef] [PubMed]
[89] Maki, D.G., Kluger, D.M. and Crnich, C.J. (2006) The Risk of Bloodstream Infection in Adults with Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies. Mayo Clinic Proceedings Home, 81, 1159-1171. [Google Scholar] [CrossRef] [PubMed]
[90] Lebeaux, D., Fern_andez-Hidalgo, N., Chauhan, A., et al. (2014) Management of Infections Related to Totally Implantable Venousaccess Ports: Challenges and Perspectives. The Lancet Infectious Diseases, 14, 146-159. [Google Scholar] [CrossRef] 
[91] Mermel, L.A., Allon, M., Bouza, E., et al. (2009) Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America. Clinical Infectious Diseases, 49, 1-45. [Google Scholar] [CrossRef] [PubMed]
[92] Honda, H., Krauss, M.J., Jones, J.C., et al. (2010) The Value of Infec-tious Diseases Consultation in Staphylococcus Aureus Bacteremia. The American Journal of Medicine, 123, 631-637. [Google Scholar] [CrossRef] [PubMed]
[93] Denny, M.A. and Frank, L.R. (2003) Ventricular Tachycardia Secondary to Porta-Cath Fracture and Embolization. Journal of Emergency Medicine, 24, 29-34. [Google Scholar] [CrossRef] 
[94] Di Carlo, I., Fisichella, P., Russello, D., et al. (2000) Catheter Fracture and Cardiac Migration: A Rare Complication of Totally Implantable venous Devices. Journal of Surgi-cal Oncology, 73, 172-173. [Google Scholar] [CrossRef] 
[95] Sugimoto, T., Nagata, H., Hayashi, K., et al. (2012) Pinch-Off Syndrome: Transection of Implantable Central venous Access Device. BMJ Case Reports, 2012. [Google Scholar] [CrossRef] [PubMed]
[96] Bessoud, B., de Baere, T., Kuoch, V., et al. (2003) Experience at a Single Institution with Endovascular Treatment of Mechanical Complications Caused by Implanted Cen-tral venous Access Devices in Pediatric and Adult Patients. American Roentgen Ray Society, 180, 527-532. [Google Scholar] [CrossRef] [PubMed]
[97] Cheng, C.C., Tsai, T.N., Yang, C.C., et al. (2009) Percu-taneous Retrieval of Dislodged Totally Implantable Central venous Access System in 92 Cases: Experience in a Single Hospital. European Journal of Radiology, 69, 346-350. [Google Scholar] [CrossRef] [PubMed]
[98] Cataldo, R., Costa, F., Vitiello, M., et al. (2014) The Mystery of the Occluded Port that Allowed Blood Withdrawal: Is It Safe to Use Standard Needles to Access Ports? A Case Report and Literature Review. Journal of Surgical Oncology, 109, 500-503. [Google Scholar] [CrossRef] [PubMed]
[99] Powers, M.L., Lublin, D., Eby, C., et al. (2009) Safety Concerns Related to Use of Unapproved Needles for Accessing Implantable venous Access Devices. Transfusion, 49, 2008-2009. [Google Scholar] [CrossRef] [PubMed]
[100] Conway, M.A., McCollom, C. and Bannon, C. (2014) Central venous Catheter Flushing Recommendations: A Systematic Evidence-Based Practice Review. Journal of Pediatric Hematology/Oncology Nursing, 31, 185-190. [Google Scholar] [CrossRef] [PubMed]
[101] Goossens, G.A. (2015) Flushing and Locking of venous Cathe-ters: Available Evidence and Evidence Deficit. Nursing Research and Practice, 2015, Article ID: 985686. [Google Scholar] [CrossRef] [PubMed]
[102] Garajov_a, I., Nepoti, G., Paragona, M., et al. (2013) Port-a-Cath-Related Complications in 252 Patients with Solid Tissue Tumours and the First Report of Heparin-Induced Delayed Hypersensitivity after Port-a-Cath Heparinisation. European Journal of Cancer Care, 22, 125-132. [Google Scholar] [CrossRef] [PubMed]
[103] Sona, C., Prentice, D. and Schallom, L. (2012) National Survey of Central venous Catheter Flushing in the Intensive Care Unit. Critical Care Nurse, 32, e12-e19. [Google Scholar] [CrossRef] [PubMed]
[104] Goossens, G.A., Jerome, M., Janssens, C., et al. (2013) Com-paring Normalsaline versus Diluted Heparin to Lock Non-Valved Totally Implantable venous Access Devices in Cancer Patients: A Randomised, Non-Inferiority, Open Trial. Annals of Oncology, 24, 1892-1899. [Google Scholar] [CrossRef] [PubMed]
[105] Dal Molin, A., Clerico, M., Baccini, M., et al. (2015) Normal Saline versus Heparin Solution to Lock Totally Implanted venous Access Devices: Results from a Multicenter Randomized Trial. European Journal of Oncology Nursing, 19, 638-643. [Google Scholar] [CrossRef] [PubMed]
[106] Ignatov, A., Ignatov, T., Taran, A., et al. (2010) Interval between Port Catheter Flushing Can Be Extended to Four Months. Gynecologic and Obstetric Investigation, 70, 91-94. [Google Scholar] [CrossRef] [PubMed]
[107] Diaz, J.A., Rai, S.N., Wu, X., et al. (2017) Phase II Trial on Ex-tending the Maintenance Flushing Interval of Implanted Ports. Journal of Oncology Practice, 13, e22-e28. [Google Scholar] [CrossRef] 
[108] Weingart, S.N., Hsieh, C., Lane, S., et al. (2014) Stand-ardizing Central venous Catheter Care by Using Observations from Patientswith Cancer. Clinical Journal of Oncology Nursing, 18, 321-326. [Google Scholar] [CrossRef]